on 26 Apr 2024
Last Applicant/ Owned by
Chuo-ku Tokyo 103-8426
JP
Serial Number
79198613 filed on 23rd Sep 2016
Registration Number
5303902 registered on 10th Oct 2017
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
The color(s) purple and orange is/are claimed as a feature of the mark. Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskelRead More
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease
No 79198613
No Service/Collective Mark
No 8T17692353
No
No
No
No
Yes
Yes
No
No
26.01.21 -
Circles that are totally or partially shaded
26.03.03 -
Incomplete ovals
26.13.21 -
Quadrilaterals that are completely or partially shaded
26.17.09 -
Curved line(s), band(s) or bar(s)
| Status Date | Action Taken |
|---|---|
| 26th Apr 2024 | CANCELLE SECTION 71 |
| 10th Oct 2022 | COURTESY REMINER - SEC. 71 (6-YR) E-MAILE |
| 03rd Jul 2022 | NEW REPRESENTATIVE AT IB RECEIVE |
| 10th Feb 2018 | INAL ECISION TRANSACTION PROCESSE BY IB |
| 24th Jan 2018 | INAL ISPOSITION PROCESSE |
| 24th Jan 2018 | INAL ISPOSITION NOTICE SENT TO IB |
| 10th Jan 2018 | INAL ISPOSITION NOTICE CREATE, TO BE SENT TO IB |
| 10th Oct 2017 | REGISTERE-PRINCIPAL REGISTER |
| 25th Jul 2017 | OICIAL GAZETTE PUBLICATION CONIRMATION E-MAILE |
| 25th Jul 2017 | PUBLISHE OR OPPOSITION |
